Non-invasive foetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma

European Journal of Clinical Investigation

Volumn 39, Issue 7, 2009, Pages 607-617

  Wang, X D ^a,b   Wang, B L ^b,d   Ye, S L ^b   Liao, Y Q ^b   Wang, L F ^c   He, Z M ^a  

^a Central South University   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Hefei Maternal and Child Health Hospital   (China)

^d Affiliated Provincial Hospital   (China)

Author keywords

Foetal DNA; Maternal plasma; Prenatal diagnosis; RHD gene

Indexed keywords

DNA;

ARTICLE; BLOOD GROUP RH; CHINESE; CONTROLLED STUDY; EXON; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FEMALE; FETUS; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GESTATIONAL AGE; HUMAN; MATERNAL PLASMA; MICROSATELLITE MARKER; NEWBORN; NON INVASIVE MEASUREMENT; NUCLEOTIDE SEQUENCE; POLYMORPHIC LOCUS; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; SHORT TANDEM REPEAT; UMBILICAL CORD BLOOD;

ASIAN CONTINENTAL ANCESTRY GROUP; DNA; FEMALE; FETUS; GENOTYPE; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM;

EID: 66849118920     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02148.x     Document Type: Article

References (41)

1. Daniels G, Finning K, Martin P, Soothill P. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 2004 87 : 225 32.
2. Grootkerk-Tax MG, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006 46 : 2142 8.
3. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. J Histochem Cytochem 2005 53 : 301 5.
4. Rouillac-Le Sciellour C, Puillandre P, Gillot R, Baulard C, Métral S, Le Van Kim C et al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004 8 : 23 31. (Pubitemid 38989470)
5. Brojer E, Zupanska B, Guz K, Orziñska A, Kaliñska A. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 2005 45 : 1473 80.
6. Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 2005 25 : 1040 4.
7. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004 1022 : 119 23.
8. Lan JC, Chen Q, Wu DL, Ding H, Pong DB, Zhao T. Genetic polymorphism of RhD-negative associated haplotypes in the Chinese. J Hum Genet 2000 45 : 224 7.
9. Yan LY, Wu JJ, Zhu FM, Hong X, Xu X. Molecular basis of D variants in Chinese person. Transfusion 2007 47 : 471 7.
10. Ye LY, Guo ZH, Li Q, Zhu ZY. Molecular and family analyses revealed two novel RHD alleles in a survey of a Chinese RhD-negative population. Vox Sang 2007 92 : 242 6.
11. Peng CT, Shih MC, Liu TC, Lin IL, Jaung SJ, Chang JG. Molecular basis for the RhD negative phenotype in Chinese. Int J Mol Med 2003 11 : 515 21.
12. Lee YL, Chiou HL, Hu SN, Wang L. Analysis of RHD genes in Taiwanese RhD-negative donors by the multiplex PCR method. J Clin Lab Anal 2003 17 : 80 4.
13. Shao CP, Xiong W. A new hybrid RHD-positive, D antigen-negative allele. Transfus Med 2004 14 : 185 6.
14. Xu Q, Grootkerk-Tax MG, Maaskant-van Wijk PA, van der Schoot CE. Systemic analysis and zygosity determination of the RHD gene in a D-negative Chinese Han population reveals a novel D-negative RHD gene. Vox Sang 2005 88 : 35 40.
15. Wagner FF, Flegel WA. RHCE represents the ancestral RH position, while RHD is the duplicated gene. Blood 2002 99 : 2272 3.
16. Mouro I, Colin Y, Cherif-Zahar B, Cartron JP, Le Van Kim C. Molecular genetic basis of the human Rhesus blood group system. Nat Genet 1993 5 : 62 5.
17. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000 95 : 3662 8.
18. Chiu RW, Murphy MF, Fidler C, Zee BC, Wainscoat JS, Lo YM. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem 2001 47 : 667 72.
19. Avent ND. High variability of the RH locus in different ethnic backgrounds. Transfusion 2005 45 : 293 4.
20. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999 93 : 385 93.
21. Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000 95 : 375 87.
22. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A et al. The presence of an RHD pseudogene containing a 37 bp duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000 95 : 12 8.
23. Vengelen-Tyler V. Technical Manual. 12th ed. Bethesda, MD : American Association of Blood Banks 1996.
24. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001 2 : 10.
25. Fukumori Y, Hori Y, Ohnoki S, Nagao N, Shibata H, Okubo Y et al. Further analysis of Del (D-eluate) using polymerase chain reaction (PCR) with RHD gene-specific primers. Transfus Med 1997 7 : 227 31.
26. Wagner T, Körmöczi GF, Buchta C, Vadon M, Lanzer G, Mayr WR et al. Anti-D immunization by Del red blood cells. Transfusion 2005 45 : 520 6.
27. Gassner C, Doescher A, Drnovsek TD, Rozman P, Eicher NI, Legler TJ et al. Presence of RHD in serologically D-,C/E+ individuals: a European multicenter study. Transfusion 2005 45 : 527 38.
28. Chang JG, Wang JC, Yang TY, Tsan KW, Shih MC, Peng CT et al. Human RhDel is caused by a deletion of 1013 bp between introns 8 and 9 including exon 9 of RHD gene. Blood 1998 92 : 2602 4.
29. Chen JC, Lin TM, Chen YL, Wang YH, Jin YT, Yue CT. RHD1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol 2004 122 : 193 8.
30. Hromadnikova I, Houbova B, Hridelova D, Voslarova S, Kofer J, Komrska V et al. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination. Prenat Diagn 2003 23 : 235 8.
31. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002 42 : 1079 85.
32. Legler TJ, Lynen R, Maas JH, Pindur G, Kulenkampff D, Suren A et al. Prediction of fetal RhD and RhCcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apher Sci 2002 27 : 217 23.
33. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998 339 : 1734 8.
34. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Kulovany E et al. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 2005 20 : 275 80.
35. van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC. Prenatal typing of Rh and kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003 17 : 31 44. (Pubitemid 36042643)
36. Randen I, Hauge R, Kjedsen-Kragh J, Fagerhol MK. Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 2003 85 : 300 6.
37. Zhou L, Thorson JA, Nugent C, Davenport RD, Butch SH, Judd WJ. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women. Am J Obstet Gynecol 2005 193 : 1966 71.
38. Machado IN, Castilho L, Pellegrino J Jr., Barini R. Fetal RHD genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras 2006 52 : 232 5.
39. Shao CP, Maas JH, Su YQ, Köhler M, Legler TJ. Molecular background of RhD positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002 83 : 156 61.
40. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Three molecular structures cause Rhesus D category VI phenotypes with distinct immunohematologic features. Blood 1998 91 : 2157 68.
41. Kim JY, Kim SY, Kim CA, Yon GS, Park SS. Molecular characterization of D-Korean persons: development of a diagnostic strategy. Transfusion 2005 45 : 345 52.